BRNS
Barinthus Biotherapeutics
BRNS
BRNS
12 hedge funds and large institutions have $18.4M invested in Barinthus Biotherapeutics in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.19%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
2
Increased
2
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$7.07K |
| 2 |
IIM
Ipswich Investment Management
Beverly,
Massachusetts
|
+$5.19K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AI
1
Alphabet Inc
Mountain View,
California
| $7.87M | -$992K | -190,700 | -11% |
|
|
DF
2
DC Funds
Mclean,
Virginia
| $3.34M | – | – | – |
|
|
LIP
3
Liontrust Investment Partners
London,
United Kingdom
| $3.12M | – | – | – |
|
|
BCM
4
BlueCrest Capital Management
St Helier,
Jersey
| $2.82M | -$2.08K | -400 | -0.1% |
|
|
JHU
5
Johns Hopkins University
Baltimore,
Maryland
| $561K | – | – | – |
|
6
Millennium Management
New York
| $357K | -$11.9K | -2,287 | -3% |
|
|
IIM
7
Ipswich Investment Management
Beverly,
Massachusetts
| $272K | +$5.19K | +1,000 | +2% |
|
8
Morgan Stanley
New York
| $48K | -$1.72K | -333 | -3% |
|
|
9
UBS Group
Zurich,
Switzerland
| $10K | +$7.07K | +1,383 | +241% |
|
|
MGIM
10
M&G Investment Management
London,
United Kingdom
| $5.44K | – | – | – |
|
11
Hudson Bay Capital Management
Stamford,
Connecticut
| – | -$462K | -41,599 | Closed |
|
|
ACA
12
Arena Capital Advisors
Los Angeles,
California
| – | -$341K | -30,698 | Closed |
|
|
EMG
13
ETF Managers Group
Summit,
New Jersey
| – | -$108K | -10,087 | Closed |
|
14
Wells Fargo
San Francisco,
California
| – | -$6K | -500 | Closed |
|